CRH PUBLIC LTD CO financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data CRH PUBLIC LTD CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	31,648	31,689	25,888	29,206	32,723	34,949	35,572	37,447
Cost of revenue	18,391	18,859	17,323	19,379	21,908	22,986	22,871	23,919
Gross profit	9,058	9,273	8,565	9,827	10,815	11,963	12,701	13,528
Selling, general and administrative				6,538	7,056	7,486	7,852	8,283
Operating income	2,446	2,793	2,026	3,327	3,809	4,186	4,925	5,440
Interest expense	399	387	438	315	344	376	612	810
Interest income	39	22	0	0	65	206	143	146
Other non-operating income				90	-69	-2	258	29
Pre-tax income	1,968	2,181	1,454	3,102	3,461	4,014	4,714	4,805
Income tax	467	534	445	650	762	925	1,085	1,041
Income from continuing operations	1,501	1,647	1,009	2,442	2,684
Net income to minority interests	5	21	43	56	27
Net income	2,884	1,717	1,122	2,630	3,862	3,178	3,492	3,753
EBITDA				4,878	5,386	5,819	6,723	7,596
EPS, basic	3.47	2.14	1.43	3.35	5.15	4.36	5.06	5.54
EPS, diluted	3.45	2.13	1.42	3.32	5.11	4.33	5.02	5.51
Shares, basic (weighted)				780	758	724	683	673
Shares, diluted (weighted)				787	764	729	690	677
Dividend per share				1.21	1.27	1.33	1.40	1.48

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2,686	4,218	7,721	5,783	5,936	6,341	3,720	4,096
Receivables	4,665	4,231	4,086	4,569	4,569
Inventory	3,505	3,080	3,117	3,611	4,194	4,291	4,755	5,251
Other current assets					403	478	749	678
Total current assets	17,395	17,258	14,977	14,044	14,833	16,885	14,083	15,254
Property, plant and equipment	18,046	19,574	19,317	19,502	17,768	17,841	21,452	24,937
Lease right-of-use assets					1,175	1,292	1,274	1,471
Goodwill		9,093	9,032	9,451	9,199	9,158	11,061	13,099
Intangible assets					1,088	1,041	1,211	2,048
Other non-current assets					607	632	795	1,018
Total assets	46,777	47,612	44,944	44,670	45,319	47,469	50,613	58,329
Accounts payable	5,277	4,916	4,792	5,692	2,930	3,149	3,207	3,263
Accrued liabilities					2,132	2,296	2,248	2,196
Short-term debt					1,491	1,866	2,999	1,175
Total current liabilities	13,466	12,866	7,465	7,581	8,041	10,013	10,296	8,754
Long-term debt					8,145	9,776	10,969	16,478
Lease liabilities		1,393	1,339	1,374	1,000	1,125	1,074	1,232
Other non-current liabilities					2,208	2,196	2,319	2,876
Total liabilities	27,825	27,977	24,596	23,756	22,279	25,848	27,763	32,851
Total debt		15,827	12,215	10,487	9,542	11,535	13,851	17,533
Paid-in capital	7,493	7,493	7,493	0	443	454	422	397
Retained earnings	11,705	11,350	11,565	19,770	22,495	22,918	24,036	25,593
Treasury stock					-297	-2,199	-2,137	-2,016
Other comprehensive income					-787	-616	-1,005	-257
Shareholders' equity	18,350	19,028	19,656	20,233	22,157	20,854	21,607	24,004
Minority interests	602	607	692	681	575	434	859	1,044
Total equity	18,952	19,635	20,412	21,246	22,732	21,288	22,466	25,048
Total liabilities and equity	46,777	47,612	44,944	44,670	45,319	47,469	50,613	58,329
Shares outstanding					752	735	719	669

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	2,889	1,738	1,165	2,686	3,889	3,072	3,521	3,790
Depreciation and amortization				1,551	1,577	1,633	1,798	2,156
Stock-based compensation				110	101	123	125	143
Deferred income tax				99	-63	-64	180	167
Change in receivables				-404	-226	-164	-122	121
Change in inventory				-439	-655	-60	-224	-161
Change in payables				539	403	144	48	-158
Cash from operations	2,246	3,881	3,938	3,979	3,800	5,017	4,989	5,625
Capital expenditures	-1,324	-1,374	-996	-1,554	-1,523	-1,817	-2,578	-2,713
Acquisitions				-1,494	-3,253	-640	-4,900	-3,856
Cash from investing	-1,772	217	-1,060	-2,513	-917	-2,391	-6,291	-6,045
Debt issued	1,587	106	6,427	0	38	3,163	4,001	10,479
Debt repaid	-291	-640	-4,943	-1,183	-364	-1,462	-1,859	-7,612
Stock issued	14			13	11	4	8
Share buybacks	-921	-954	-249	-896	-1,178	-3,067	-1,482	-1,181
Dividends paid	-633	-663	-722	-938	-930
Cash from financing	-226	-2,546	287	-3,107	-2,499	-2,380	-1,186	596
Exchange rate effect	-122	-20	338	-297	-231
Net change in cash				-1,938	153	454	-2,631	388
Free cash flow	922	2,507	2,942	2,425	2,277	3,200	2,411	2,912
Interest paid	394	469	432	340	329	418	599	724
Income taxes paid			-499	642	1,043	959	960	831

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $85.04 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.2%	Gross profit / revenue.
Operating margin	14.3%	Operating income / revenue.
Pre-tax margin	13.3%	Pre-tax income / revenue.
Net margin	9.9%	Net income / revenue.
Operating cash flow margin	14.0%	Cash from operations / revenue.
Effective tax rate	24.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	16.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.6%	Net income / average total assets.
Return on invested capital (ROIC)	10.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	6.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	10.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	12.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	21.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	13.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	12.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	7.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-0.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	27.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	9.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	2.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	31.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	12.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	14.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	20.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	8.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-0.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	5.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	11.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	15.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	8.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.58x	Current assets / current liabilities.
Quick ratio	0.30x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.30x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.74x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.4%	Total debt / total assets.
Liabilities / assets	56.4%	Total liabilities / total assets.
Net debt	$14.80B	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	6.49x	Operating income / interest expense.
Working capital	$5.78B	Current assets - current liabilities.
Goodwill and intangibles / assets	25.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$8.85B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.66x	Revenue / average total assets.
Fixed asset turnover	1.55x	Revenue / average property, plant and equipment.
Inventory turnover	4.83x	Cost of revenue / average inventory.
Days inventory	76 days	365 x average inventory / cost of revenue.
Days payables	52 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.74	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$57.76	Revenue / diluted weighted shares.
Operating cash flow per share	$8.10	Cash from operations / diluted weighted shares.
Book value per share	$36.09	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$13.29	Tangible book value / shares outstanding.
Cash per share	$4.54	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$56.92B	Share price x shares outstanding.
Enterprise value	$71.72B	Market cap + total debt - cash - short-term investments.
P/E	14.8x	Market cap / net income. Only when net income is positive.
P/S	1.47x	Market cap / revenue.
P/B	2.37x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.43x	Market cap / tangible book value, when positive.
P/OCF	10.5x	Market cap / cash from operations, when positive.
EV/Sales	1.86x	Enterprise value / revenue.
EV/EBIT	13.0x	Enterprise value / operating income, when both are positive.
Earnings yield	6.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	2.0%	(Dividends paid + share buybacks) / market cap.
PEG	5.83x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CRH PUBLIC LTD CO's revenue in fiscal 2025?

CRH PUBLIC LTD CO reported revenue of $37.45B for fiscal 2025, 5.3% higher than the year before.

Was CRH PUBLIC LTD CO profitable in fiscal 2025?

Yes. Net income was $3.75B, a net margin of 10%.

How much free cash flow did CRH PUBLIC LTD CO generate in fiscal 2025?

Cash from operations of $5.63B minus capital expenditures of $2.71B left free cash flow of $2.91B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CRH PUBLIC LTD CO